Summary

The nutraceuticals market size is projected to reach US$ 500.77 billion in 2023 to US$ 895.76 billion by 2031; it is estimated to register a CAGR of 7.5% from 2023 to 2031.

Nutraceuticals are associated with various medicinal and health benefits, which is increasing its popularity among consumers. Rising healthcare costs, coupled with the increasing geriatric population across the globe propelling the adoption of various nutraceuticals such as dietary supplements, functional food and beverages, sports nutrition products, etc. Growing consumer focus on preventive health, increasing instances of lifestyle-related disorders, and rising consumer focus on health-promoting diets boost the demand for nutraceuticals. Moreover, Consumers’ attitude is observed to be very positive towards functional foods mainly on account of the added health and wellness benefits offered by these products. Thus, the nutraceutical market is significantly growing across the globe.

Awareness regarding health and nutrition has increased significantly in the past few years. With busy lifestyles and hectic work schedules, people fail to concentrate on their health, fitness, and nutrition. This has led to an increase in the prevalence of diseases such as obesity, diabetes, high blood pressure, skin problems, and digestive issues. The World Health Organization (WHO) refers to cardiovascular diseases as a leading cause of death across the world. According to a report from the World Heart Federation (WHF), the number of death cases from cardiovascular diseases rose from 12.1 million in 1990 to 20.5 million in 2021. Such a high prevalence of cardiovascular diseases drives consumer focus toward preventive health. As a result, the demand for nutraceuticals such as dietary supplements, and functional food and beverages with nutritional benefits has increased among the masses as they focus on preventive health. Nutraceuticals support the healthy functioning of the digestive tract, spanning from mouth to gut, along with controlling the growth of harmful microorganisms inside these organs. Consumers preferably opt for self-directed care while receiving treatment for lifestyle illnesses such as malnutrition and cardiovascular disorders, which is further contributing to the surging demand for dietary supplements and nutraceuticals. After the COVID-19 pandemic, there has been a sharp rise in the popularity of functional foods and dietary supplements, as people have been prioritizing their health and actively searching for healthy alternatives and fitness activities to prevent lifestyle-related illnesses. Thus, immunity-boosting supplements have gained significant popularity in the last few years due to altered consumer behavior and purchasing habits. Thus, the rising consumer focus on preventive health bolsters the growth of the nutraceuticals market.

Based on type, the nutraceuticals market is segmented into functional foods, functional beverages, and dietary supplements. Further, the nutraceuticals market is sub-segmented into general wellness, sports nutrition, weight management, immune health, and others. The functional food segment held a larger share of the market in 2023. Functional food products are formulated in such a way that they contain substances or ingredients that add a health-enhancing or disease-preventing value to them; these functional ingredients are incorporated at concentrations that are sufficiently high to achieve the intended benefits but are safe for consumption. Foods enriched and fortified with nutritional ingredients are part of the functional food. These food products are fortified with specific components or nutritional additives such as omega-3 fatty acids, vitamins, fibers, and minerals to promote optimal health by reinforcing the body's immune systems and reducing the risk of certain diseases. For example, breakfast cereals are usually fortified with nutrients such as vitamins, iron, calcium, and probiotics. Functional food products go beyond standard daily nutrient intake to provide targeted health benefits. They can aid in cholesterol management, improved bone health, and improved heart health, among other benefits. Major brands are increasingly focused on introducing low-sugar and no-sugar functional food, which helps them to stay competitive in the market.

The overall nutraceuticals market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers—along with external consultants such as valuation experts, research analysts, and key opinion leaders—specializing in the nutraceuticals market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Nutraceuticals Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
4.2.1 Porter's Five Forces Analysis
4.2.2 Bargaining Power of Suppliers
4.2.3 Bargaining Power of Buyers
4.2.4 Threat of New Entrants
4.2.5 Competitive Rivalry
4.2.6 Threat of Substitutes
4.3 Ecosystem Analysis
4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors or Suppliers
4.3.4 Retailers
4.4 List of Vendors in the Value Chain
5. Nutraceuticals Market – Key Market Dynamics
5.1 Nutraceuticals Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Consumer Focus on Preventive Health
5.2.2 Innovations and Strategic Developments by Market Players
5.3 Market Restraints
5.3.1 Complexity of Regulations
5.4 Market Opportunities
5.4.1 Rising Penetration of E-Commerce
5.5 Future Trends
5.5.1 Plant-Based and Organic Nutraceuticals
5.6 Impact of Drivers and Restraints:
6. Nutraceuticals Market – Global Market Analysis
6.1 Nutraceuticals Market Revenue (US$ Billion), 2021–2031
6.2 Nutraceuticals Market Forecast Analysis
7. Nutraceuticals Market Analysis – by Type
7.1 Functional Foods
7.1.1 Overview
7.1.2 Functional Foods: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.2 Functional Beverages
7.2.1 Overview
7.2.2 Functional Beverages: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3 Dietary Supplements
7.3.1 Overview
7.3.2 Dietary Supplements: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3.3 General Wellness
7.3.3.1 Overview
7.3.3.2 General Wellness: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3.4 Sports Nutrition
7.3.4.1 Overview
7.3.4.2 Sports Nutrition: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3.5 Weight Management
7.3.5.1 Overview
7.3.5.2 Weight Management: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3.6 Immune Health
7.3.6.1 Overview
7.3.6.2 Immune Health: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3.7 Others
7.3.7.1 Overview
7.3.7.2 Others: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
8. Nutraceuticals Market Analysis – by Distribution Channel
8.1 Supermarkets and Hypermarkets
8.1.1 Overview
8.1.2 Supermarkets and Hypermarkets: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
8.2 Specialty Stores
8.2.1 Overview
8.2.2 Specialty Stores: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
8.3 Online Retail
8.3.1 Overview
8.3.2 Online Retail: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
8.4 Convenience Stores
8.4.1 Overview
8.4.2 Convenience Stores: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
8.5 Others
8.5.1 Overview
8.5.2 Others: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9. Nutraceuticals Market – Geographical Analysis
9.1 Overview
9.2 North America
9.2.1 North America Nutraceuticals Market Overview
9.2.2 North America: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.2.3 North America: Nutraceuticals Market Breakdown, by Type
9.2.3.1 North America: Nutraceuticals Market – Revenue and Forecast Analysis – by Type
9.2.4 North America: Nutraceuticals Market Breakdown, by Distribution Channel
9.2.4.1 North America: Nutraceuticals Market – Revenue and Forecast Analysis – by Distribution Channel
9.2.5 North America: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.2.5.1 North America: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.2.5.2 United States: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.2.5.2.1 United States: Nutraceuticals Market Breakdown, by Type
9.2.5.2.2 United States: Nutraceuticals Market Breakdown, by Distribution Channel
9.2.5.3 Canada: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.2.5.3.1 Canada: Nutraceuticals Market Breakdown, by Type
9.2.5.3.2 Canada: Nutraceuticals Market Breakdown, by Distribution Channel
9.2.5.4 Mexico: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.2.5.4.1 Mexico: Nutraceuticals Market Breakdown, by Type
9.2.5.4.2 Mexico: Nutraceuticals Market Breakdown, by Distribution Channel
9.3 Europe
9.3.1 Europe Nutraceuticals Market Overview
9.3.2 Europe: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.3 Europe: Nutraceuticals Market Breakdown, by Type
9.3.3.1 Europe: Nutraceuticals Market – Revenue and Forecast Analysis – by Type
9.3.4 Europe: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.4.1 Europe: Nutraceuticals Market – Revenue and Forecast Analysis – by Distribution Channel
9.3.5 Europe: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.3.5.1 Europe: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.3.5.2 Germany: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.2.1 Germany: Nutraceuticals Market Breakdown, by Type
9.3.5.2.2 Germany: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.5.3 France: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.3.1 France: Nutraceuticals Market Breakdown, by Type
9.3.5.3.2 France: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.5.4 Italy: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.4.1 Italy: Nutraceuticals Market Breakdown, by Type
9.3.5.4.2 Italy: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.5.5 Spain: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.5.1 Spain: Nutraceuticals Market Breakdown, by Type
9.3.5.5.2 Spain: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.5.6 United Kingdom: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.6.1 United Kingdom: Nutraceuticals Market Breakdown, by Type
9.3.5.6.2 United Kingdom: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.5.7 Rest of Europe: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.7.1 Rest of Europe: Nutraceuticals Market Breakdown, by Type
9.3.5.7.2 Rest of Europe: Nutraceuticals Market Breakdown, by Distribution Channel
9.4 Asia Pacific
9.4.1 Asia Pacific Nutraceuticals Market Overview
9.4.2 Asia Pacific: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.3 Asia Pacific: Nutraceuticals Market Breakdown, by Type
9.4.3.1 Asia Pacific: Nutraceuticals Market – Revenue and Forecast Analysis – by Type
9.4.4 Asia Pacific: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.4.1 Asia Pacific: Nutraceuticals Market – Revenue and Forecast Analysis – by Distribution Channel
9.4.5 Asia Pacific: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.4.5.1 Asia Pacific: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.4.5.2 China: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.2.1 China: Nutraceuticals Market Breakdown, by Type
9.4.5.2.2 China: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.5.3 Japan: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.3.1 Japan: Nutraceuticals Market Breakdown, by Type
9.4.5.3.2 Japan: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.5.4 India: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.4.1 India: Nutraceuticals Market Breakdown, by Type
9.4.5.4.2 India: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.5.5 Australia: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.5.1 Australia: Nutraceuticals Market Breakdown, by Type
9.4.5.5.2 Australia: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.5.6 South Korea: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.6.1 South Korea: Nutraceuticals Market Breakdown, by Type
9.4.5.6.2 South Korea: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.5.7 Rest of Asia Pacific: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.7.1 Rest of Asia Pacific: Nutraceuticals Market Breakdown, by Type
9.4.5.7.2 Rest of Asia Pacific: Nutraceuticals Market Breakdown, by Distribution Channel
9.5 Middle East and Africa
9.5.1 Middle East and Africa Nutraceuticals Market Overview
9.5.2 Middle East and Africa: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.5.3 Middle East and Africa: Nutraceuticals Market Breakdown, by Type
9.5.3.1 Middle East and Africa: Nutraceuticals Market – Revenue and Forecast Analysis – by Type
9.5.4 Middle East and Africa: Nutraceuticals Market Breakdown, by Distribution Channel
9.5.4.1 Middle East and Africa: Nutraceuticals Market – Revenue and Forecast Analysis – by Distribution Channel
9.5.5 Middle East and Africa: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.5.5.1 Middle East and Africa: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.5.5.2 South Africa: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.5.5.2.1 South Africa: Nutraceuticals Market Breakdown, by Type
9.5.5.2.2 South Africa: Nutraceuticals Market Breakdown, by Distribution Channel
9.5.5.3 Saudi Arabia: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.5.5.3.1 Saudi Arabia: Nutraceuticals Market Breakdown, by Type
9.5.5.3.2 Saudi Arabia: Nutraceuticals Market Breakdown, by Distribution Channel
9.5.5.4 United Arab Emirates: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.5.5.4.1 United Arab Emirates: Nutraceuticals Market Breakdown, by Type
9.5.5.4.2 United Arab Emirates: Nutraceuticals Market Breakdown, by Distribution Channel
9.5.5.5 Rest of Middle East and Africa: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.5.5.5.1 Rest of Middle East and Africa: Nutraceuticals Market Breakdown, by Type
9.5.5.5.2 Rest of Middle East and Africa: Nutraceuticals Market Breakdown, by Distribution Channel
9.6 South and Central America
9.6.1 South and Central America Nutraceuticals Market Overview
9.6.2 South and Central America: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.6.3 South and Central America: Nutraceuticals Market Breakdown, by Type
9.6.3.1 South and Central America: Nutraceuticals Market – Revenue and Forecast Analysis – by Type
9.6.4 South and Central America: Nutraceuticals Market Breakdown, by Distribution Channel
9.6.4.1 South and Central America: Nutraceuticals Market – Revenue and Forecast Analysis – by Distribution Channel
9.6.5 South and Central America: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.6.5.1 South and Central America: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.6.5.2 Brazil: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.6.5.2.1 Brazil: Nutraceuticals Market Breakdown, by Type
9.6.5.2.2 Brazil: Nutraceuticals Market Breakdown, by Distribution Channel
9.6.5.3 Argentina: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.6.5.3.1 Argentina: Nutraceuticals Market Breakdown, by Type
9.6.5.3.2 Argentina: Nutraceuticals Market Breakdown, by Distribution Channel
9.6.5.4 Rest of South and Central America: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.6.5.4.1 Rest of South and Central America: Nutraceuticals Market Breakdown, by Type
9.6.5.4.2 Rest of South and Central America: Nutraceuticals Market Breakdown, by Distribution Channel
10. Competitive Landscape
10.1 Heat Map Analysis by Key Players
10.2 Company Positioning & Concentration
11. Industry Landscape
11.1 Overview
11.2 Agreements, Collaborations, And Joint Ventures
11.3 Product Launch
11.4 Expansions And Other Strategic Developments
12. Company Profiles
12.1 Glanbia Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 NOW Health Group Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Amway Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Nature's Bounty
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Garden of Life LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Danone SA
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 GNC Holdings LLC
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Quest Nutrition LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Kellanova
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Chobani LLC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners